Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in ...
Are you looking for investment growth without all the monitoring and activity that growth portfolios usually require? Well, ...
Farther Finance Advisors LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
CRISPR Therapeutics AG (CRSP) closed at $41.17 in the latest trading session, marking a -1.84% move from the prior day.
Valuations for popular ETFs focused on US stocks are reaching extremes; investors should seek stocks with low risks and high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results